Tanya E. Kelly - Publications

Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination.

Journal: British journal of cancer

Published: April 16, 2025

A pilot study evaluating the feasibility of enriching and detecting circulating tumour cells from peripheral and ovarian veins in rare epithelial ovarian carcinomas.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: December 23, 2024

Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma.

Journal: Cancer letters

Published: July 04, 2024

Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy.

Journal: Frontiers in cell and developmental biology

Published: January 25, 2023

Circulating tumour cells: The Good, the Bad and the Ugly.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: July 06, 2022

Ex vivo expansion of circulating tumour cells (CTCs).

Journal: Scientific reports

Published: May 19, 2022

The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon.

Journal: Translational oncology

Published: September 15, 2021

Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?

Journal: Molecular cancer

Published: November 11, 2020

Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy.

Journal: Breast cancer research and treatment

Published: March 24, 2020